UK Regulator Approves First Oral GLP-1 Medication for Weight Loss

The Medicines and Healthcare products Regulatory Agency in the UK has granted authorization for the country's first GLP-1 tablet specifically for weight management. This decision marks a notable development in the treatment options available for individuals seeking to manage their weight. The approval was part of a busy week for regulators, including other oncology decisions by the FDA.